Filters: Author is Ho, E [Clear All Filters]
Research Grants and Contracts
Bray TM, Ho E.
2004. Diet, endocrin-immune interactions and prostate cancer $1,300,000. National Institutes of Health. Bray, T, Principal Investigator, Ho, E, Co-Investigator:2004-2009.
Bray TM, Ho E.
2005. Diet, Endocrine-Immune Interactions & Prostate Cancer $205,000. National Institute of Health and National Cancer Institute. Co-Investigator:2005-2009.
Ho E.
2007. Dietary HDAC inhibitors in prostate cancer prevention $293,440 direct. National Institutes of Health-National Cancer Institute. Principal Investigator:2007-2012.
Ho E.
2006. Dietary inhibitors of histone deacetylase in prostate cancer prevention $30,000. Medical Research Foundation and Oregon Health and Science University. Principal Investigator:2006-2007.
Ho E.
2004. Gene expression profiling in zinc deficiency $4,900. College of Health and Human Sciences pilot. Principal Investigator:2004-2005.
Ho E.
2004. Gene expression profiling with zinc supplementation $10,000. Oregon State University, General Research Fund. Principal Investigator:2004-2005.
Ho E.
2005. Serum carotenoids in insitu and invasive cervical cancer $3,969. Northwest Health Foundation. Principal Investigator:2005-2006.
Ho E.
2005. USDA-NRI-Zinc, gene expression & DNA damage $375,000. USDA-NRI grant. :2005-2008.
Ho E.
2005. Zinc in age-related macular degeneration $20,000. Linus Pauling Institute Pilot Grant. Principal Investigator :2005-2007.
Ho E.
2004. Zinc in prostate cancer $22,138. Northwest Health Foundation. Principal Investigator:2004-2006.
Journal Articles
Trevisiol CH, Turner RT, Pfaff JE, Hunter JC, Menagh PJ, Hardin K, Ho E, Iwaniec UT.
2007. Impaired Osteoinduction in a Rat Model for Chronic Alcohol Abuse. Bone. 41(2):175-180.
Kiernan TJ, O'Flaherty N, Gilmore R, Ho E, Hickey M, Tolan M, Mulcahy D, Moore DP.
2008. Abiotrophia defectiva endocarditis and associated hemophagocytic syndrome--a first case report and review of the literature.. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 12(5):478-82. Abstract
Wong CP, Magnusson KR, Ho E.
2010. Aging is associated with altered dendritic cells subset distribution and impaired proinflammatory cytokine production.. Experimental gerontology. 45(2):163-9. Abstract
Mustacich DJ, Gohil K, Bruno RS, Yan M, Leonard SW, Ho E, Cross CE, Traber M.
2009. Alpha-tocopherol modulates genes involved in hepatic xenobiotic pathways in mice.. The Journal of nutritional biochemistry. 20(6):469-76. Abstract
Iwaniec UT, Turner RT, Koo SI, Kaur R, Ho E, Wong CP, Bruno RS.
2009. Consumption of green tea extract results in osteopenia in growing male mice.. The Journal of nutrition. 139(10):1914-9. Abstract
Myzak MC, Ho E, Dashwood RD.
2006. Dietary agents as histone deacetylase inhibitors. Molecular Carcinogenesis. 45(6):443-446.
Dashwood RH, Ho E.
2008. Dietary agents as histone deacetylase inhibitors: sulforaphane and structurally related isothiocyanates.. Nutrition reviews. 66 Suppl 1:S36-8.
Dashwood RH, Myzak MC, Ho E.
2006. Dietary HDAC inhibitors: Time to rethink weak ligands for cancer prevention. Carcinogenesis. 27(2):344-9.
Ho E, Dashwood RH.
2010. Dietary manipulation of histone structure and function.. World review of nutrition and dietetics. 101:95-102.
Hsu A, Bruno RS, L CV, Taylor AW, Dashwood RH, Bray TM, Ho E.
2010. Dietary soy and tea mitigate chronic inflammation and prostate cancer via NFkappaB pathway in the Noble rat model.. The Journal of nutritional biochemistry. Abstract
Hsu A, Bruno RS, L CV, Taylor AW, Dashwood RH, Bray TM, Ho E.
2010. Dietary soy and tea mitigate chronic inflammation and prostate cancer via NFkappaB pathway in the Noble rat model.. The Journal of nutritional biochemistry. Abstract
Ho E, Clarke JD, Dashwood RH.
2009. Dietary sulforaphane, a histone deacetylase inhibitor for cancer prevention.. The Journal of nutrition. 139(12):2393-6. Abstract
Bruno RS, Song Y, Leonard SW, Mustacich DJ, Taylor AW, Traber M, Ho E.
2007. Dietary zinc restriction in rats alters antioxidant status and increases plasma F2 isoprostanes. Journal of Nutritional Biochemistry. 18(8):509-518.





